Median H-1B offered wage at Recursion Pharmaceuticals is $137K/year, across 13 certified filings with wage data (FY2022–2024).
This page summarizes real H-1B salary data for Recursion Pharmaceuticals, based on 19 certified Labor Condition Applications (LCAs) filed with the US Department of Labor (FY2022–2025). Figures below are drawn directly from DOL disclosure records, not modeled estimates.
Based on 13 certified filings with usable annual-wage data (FY2022–2024).
Number of certified LCA filings at each DOL prevailing wage level, real filing counts from DOL disclosure data, not estimated dollar amounts per level.
| DOL Wage Level | Certified Filings |
|---|---|
| Level I | 0 |
| Level II | 2 |
| Level III | 1 |
| Level IV | 10 |
Sponsor Intel Pro
Research 100K+ H1B sponsors with approval rates, salary data, and transfer success rates.
What is the median H1B salary at Recursion Pharmaceuticals?
The median H-1B offered wage at Recursion Pharmaceuticals is $137K/year, based on 13 certified Labor Condition Applications with usable wage data filed with the US Department of Labor (FY2022–2024). Median is used rather than a simple average because a small number of outlier or mislabeled filings can otherwise skew an average heavily. This is a real figure from DOL disclosure data, not the DOL prevailing-wage floor, which is set separately per occupation, location, and wage level.
How many H1B visas does Recursion Pharmaceuticals sponsor?
Recursion Pharmaceuticals has filed 19 certified Labor Condition Applications with a 100% certification rate according to DOL disclosure data (FY2022–2025).
Does a higher wage level improve H1B lottery odds at Recursion Pharmaceuticals?
Since February 27, 2026, USCIS weights the H-1B lottery by DOL wage level, Level IV registrations get 4 entries, Level III get 3, Level II get 2, and Level I get 1, so a higher-level offer at Recursion Pharmaceuticals also improves selection odds under the current system.